Diabetes Mellitus Community Based Screening in Minority Populations
NCT ID: NCT01591525
Last Updated: 2012-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2012-06-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesis is that community based screening designed with adequate education and follow-up, and performed by qualified medical professionals will improve diabetes care in minority communities as assessed through hemoglobin A1c levels over 8 months, and in the change in the number patients who visit/obtain their PCP within the study period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations
NCT03802825
Improving Diabetes Care and Outcomes on the South Side of Chicago
NCT01087073
Diabetes Scorecard Educational Intervention Study
NCT01339520
Diabetes Prevention Program
NCT00004992
REACH Detroit Partnership Family Intervention
NCT00800410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uncontrolled Diabetic
Individuals who were previously diagnosed with Type II Diabetes, but have a HgA1C greater than 7.0%
Education on risk factors for Type II Diabetes
one-on-one education provided by a nurse practitioner or physician
Education on Type II Diabetes
one-on-one education about having Type II Diabetes, the possible complications and treatment options provided by a physician.
Education on regular visits to a Primary Care Provider
one-on-one education about the importance of visiting a primary care provider (PCP) on a regular basis. Patients are also provided a list of PCP's accepting new patients within a 3 mile radius.
Newly diagnosed Type II Diabetic
Individuals who have never been diagnosed with Type II Diabetes, but have an HgA1c greater than 7.0%
Education on risk factors for Type II Diabetes
one-on-one education provided by a nurse practitioner or physician
Education on Type II Diabetes
one-on-one education about having Type II Diabetes, the possible complications and treatment options provided by a physician.
Education on regular visits to a Primary Care Provider
one-on-one education about the importance of visiting a primary care provider (PCP) on a regular basis. Patients are also provided a list of PCP's accepting new patients within a 3 mile radius.
Newly diagnosised pre-diabetics
Individuals who have never been diagnosed with Type II Diabetes, but have a HgA1C of 6.0%-6.9%
Education on risk factors for Type II Diabetes
one-on-one education provided by a nurse practitioner or physician
Education on Type II Diabetes
one-on-one education about having Type II Diabetes, the possible complications and treatment options provided by a physician.
Education on regular visits to a Primary Care Provider
one-on-one education about the importance of visiting a primary care provider (PCP) on a regular basis. Patients are also provided a list of PCP's accepting new patients within a 3 mile radius.
Controlled
Diabetic or non-diabetic individuals with RPCG of less than 130 mg/dl.
Education on risk factors for Type II Diabetes
one-on-one education provided by a nurse practitioner or physician
Education on regular visits to a Primary Care Provider
one-on-one education about the importance of visiting a primary care provider (PCP) on a regular basis. Patients are also provided a list of PCP's accepting new patients within a 3 mile radius.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education on risk factors for Type II Diabetes
one-on-one education provided by a nurse practitioner or physician
Education on Type II Diabetes
one-on-one education about having Type II Diabetes, the possible complications and treatment options provided by a physician.
Education on regular visits to a Primary Care Provider
one-on-one education about the importance of visiting a primary care provider (PCP) on a regular basis. Patients are also provided a list of PCP's accepting new patients within a 3 mile radius.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Women who are currently pregnant.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Steward Carney Hospital
UNKNOWN
Boston Public Housing Authority
UNKNOWN
Ethnicity and Disease Community Empowerment Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelly Lamb, MA
Role: STUDY_DIRECTOR
Ethnicity and Diseasse Community Empowerment Center
Jean Bonnet, MD
Role: PRINCIPAL_INVESTIGATOR
Ethnicity and Disease Community Empowerment Center
James Morgan, MD
Role: PRINCIPAL_INVESTIGATOR
Steward Carney Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lower Mills
Dorchester, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kelly Lamb, MA
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EADCEC-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.